Cardio-Ankle Vascular Index is Independently Associated with Future Cardiovascular Events in Outpatients with

Yuta Sato1, Daiji Nagayama, Atsuhito Saiki

  • 1Center of Diabetes, Endocrinology and Metabolism, Toho University Sakura Medical Center.

Insights

Cardio-ankle vascular index (CAVI) predicts future cardiovascular events in individuals with metabolic disorders. Higher CAVI indicates increased risk, suggesting its use for identifying patients needing intensive treatment.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Metabolic Disorders

Background:

  • Arterial stiffness is a significant risk factor for cardiovascular events.
  • Metabolic disorders, including diabetes, hypertension, and dyslipidemia, are prevalent and increase cardiovascular risk.
  • Early identification of individuals at high risk within this population is crucial for timely intervention.

Purpose of the Study:

  • To determine if cardio-ankle vascular index (CAVI), a marker of arterial stiffness, independently predicts future cardiovascular events.
  • To assess the utility of CAVI in identifying individuals with metabolic disorders who are at higher risk of cardiovascular events.

Main Methods:

  • Prospective study of 1080 outpatients with metabolic disorders (diabetes, hypertension, dyslipidemia) screened for cardiovascular events, low ankle-brachial index, and atrial fibrillation.
  • Cardio-ankle vascular index (CAVI) was measured at baseline between April 2004 and March 2006.
  • Subjects were followed for a median of 6.7 years, with new-onset myocardial infarction or angina pectoris as primary endpoints.

Main Results:

  • A total of 1003 subjects were analyzed.
  • Higher baseline CAVI quartiles were associated with increased age, male ratio, and future cardiovascular events.
  • Independent predictors of future cardiovascular events included increased CAVI (HR 1.126), male gender, smoking, diabetes mellitus, and hypertension.

Conclusions:

  • Cardio-ankle vascular index (CAVI) is an independent predictor of future cardiovascular events in individuals with metabolic disorders.
  • CAVI can help identify high-risk individuals who may benefit from more intensive therapeutic strategies.
  • This marker provides valuable prognostic information beyond traditional risk factors.
Abstract

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
659
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
745
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
1.5K
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
566
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K